Novartis (United States)

Artificial intelligence and machine learning in clinical development: a translational perspective

Pratik Shah, Francis Kendall, Sean Khozin et al.

2019 · 498 Zit.

Navigating regulatory and policy challenges for AI enabled combination devices

Snigdha Santra, Preet Kukreja, Kinshuk Saxena et al.

2024 · 35 Zit.

Technology Considerations for Enabling eSource in Clinical Research: Industry Perspective

D. G. Jennings, Amy Harris Nordo, Aruna Vattikola et al.

2020 · 5 Zit.

PCN308 Natural Language Processing to Understand the Landscape of Patient-Reported Outcomes in a Specific Disease Area

M. Michelson, Tony Chow, S. Mahida et al.

2020 · 1 Zit.

CO83 An Early Look at Literature-Based Survival Trends in Oncology Tumors: Using AI to Synthesize Published Overall Survival Data across Time in Multiple Myeloma (MM), Acute Myeloid Leukemia (AML) and Glioblastoma (GB)

M Michelson, C Pashos, S Manson

2022 · 0 Zit.